N/A N=20 Laser Assisted Liposuction and Facial Autologous Fat Grafting With the LipoLife System
Laser Assisted Liposuction
Primary: Correct Identification of Before and After Photographs — 20 Participants
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
N/A N=30 Clinical Evaluation of the Safety and Efficacy of a 1060nm Diode Laser (Abdomen)
Fat Atrophy
Primary: Number of Before and After Photograph Sets Correctly Identified by Independent, Blinded Evaluators — 54 Photo sets
N/A N=60 Low-level Laser and Lifestyle Modifications
Overweight and Obesity · Weight Loss
Primary: Change in Fat Mass From Baseline to 6 Weeks — -1.3; -2.0 Kg — p=0.19
N/A N=54 Study of Low Level Laser Light Therapy on Circumference Reduction
Circumference Reduction
Primary: Change in Combined Circumference Measurements — -5.36 inches — p=<.0001
N/A N=21 The Smartlipo Triplex 1440nm Wavelength Laser and the Sidelaze 800 Hand Piece for the Treatment of Facial Acne Scars
Acne Scars
Primary: Percentage of Participants With Facial Acne Improvement Using the Global Aesthetic Improvement Scale — 28.6; 57.1; 14.3 percentage of participants
N/A N=39 Clinical Evaluation of a 1060 nm Diode Laser, PEMF and Vacuum Assisted MP RF for Non-invasive Fat Reduction
Adipose Tissue Atrophy
Primary: Change in Aesthetic Appearance From Baseline — 0.97 score on a scale
Phase 3 N=44 Low Level Laser Treatment (LLLT) and Lorcaserin for Weight Management
Overweight · Obese
Primary: Change in Waist Circumference — -2.3; -6.0; -4.0 cm — p=0.398
N/A N=60 LLLT for Reducing Waste Circumference and Weight
Weight Loss
Primary: Change in Weight — -0.5; -0.9; -0.6 Kg — p=0.723
N/A N=72 Study of Low Level Laser Therapy for Body Contouring
Body Contouring
Primary: Incidence of the Reduction of at Least 3.0 Inches Off Their Combined Waist-hips-thighs Circumference. — 21; 2 participants
N/A N=53 Study of Low Level Laser Therapy to Reduce Body Circumference in Obese Individuals
Obesity
Primary: Difference in the Proportion of Primary Outcome Successes Between Treatment Groups for Change in Combined Circumference Measurements — 20; 3 participants — p=<0.00005
N/A N=67 Study of the Effectiveness of Green Diode Laser Light on Body Shaping
Body Contouring
Primary: Combined Circumference in Inches of the Waist, Hips and Bilateral Thighs — -3.895; -1.136 inches
N/A N=104 Low Level Laser Therapy to Reduce Pain After Breast Augmentation Surgery
Pain
Primary: Number of Participants Who Scored Less Than 30 on the 0-100 Visual Analog Scale (VAS)for Pain 24 Hours Post-operative. — 20; 37 participants — p=<0.0001
N/A N=30 Clinical Evaluation of the Safety and Efficacy of a 1060 nm Diode Laser (Flanks)
Fat Atrophy
Primary: Change in the Percentage of Fat Thickness From Baseline to 12-weeks Post-treatment — -6.9 percentage of body fat
N/A N=68 Study of the Effect of Low Level Laser Light Therapy on Reducing the Appearance of Cellulite in the Thighs and Buttocks.
Cellulite
Primary: Number of Subjects That Met the Individual Success Criteria — 19; 3 participants — p=<0.0001
N/A N=42 Laser Ablation After Stereotactic Radiosurgery
Metastatic Brain Tumors · Progression · Radiation Necrosis
Primary: Percentage of Patients With Progression-Free Survival (PFS) — 74; 74 percentage of patients
N/A N=60 Treatment of Subcutaneous Adipose Tissue in the Thighs Using High Intensity Focused Ultrasound
Treatment of Adipose Tissue in the Thighs
Primary: Clinical Improvement in Thigh Circumference — -1.22; -0.59 centimeter
N/A N=39 Comparing the Efficacy of a Dual-Frequency LLLT Device With a Sham Device as a Therapy for Adipose Tissue Loss
Obesity · Body Weight · Fat Burn
Primary: Change in Body Fat Percentage — -1.7556; 0.280 Percentage of Body Fat — p=<0.01
N/A N=31 An Evaluation of the Effect of the Erchonia Laser for Non-invasive Reduction of Submental Fat
Weight Loss
Primary: Proportion of Accurately Identified Subject Pre- and Post-treatment Photographs by at Least Two of the Three Blinded Independent Evaluators. — 26 Participants
N/A N=62 Efficacy Study of the Effect of Low Level Laser Light Therapy on Reducing Upper Arm Circumference
Body Contouring
Primary: Change in Combined Upper Arm Circumference Measurements From Baseline to Endpoint — 18; 1 participants
N/A N=12 Performance Evaluation of the truSculpt Radiofrequency Device for Lipolysis of Abdominal Fat
Body Fat
Primary: Number of Participants Who's Abdominal Tissue Showed Necrosis or Inflammatory Immune Cell Response — 10; 0 Participants
N/A N=24 Laser-Assisted Regenerative Surgical Therapy for Peri-implantitis
Peri-Implantitis
Primary: Change in Periodontal Probing Depths (PD) — 1.85; 2.65 millimeters
Phase 4 N=50 Low Level Laser Treatment and Breast Cancer Related Lymphedema
Lymphedema
Primary: LDex Change- — 28.0; 17.8; 22.2 LDex
N/A N=72 Evaluation of the Treatment of Adipose Tissue With Liposonix System (Model 2) Using a New Treatment Method
Subcutaneous Adipose Tissue
Primary: Change in Waist Circumference 12 Weeks After Treatment as Compared to Baseline — -1.6; -.96; -1.4; -1.2 cm
N/A N=10 Histopathological Evaluation of the Periodontal Ligament Subjected to Laser Ablation.
Pulp Necroses
Primary: Cell Count of Inflammatory Infiltrate Per Cross-Sectional Area at 400X Magnification — 10.3; 10.5 Cells / 0.1 mm^2
N/A N=167 Stereotactic Laser Ablation for Temporal Lobe Epilepsy (Slate)
Temporal Lobe Epilepsy
Primary: Incidence of Qualifying Adverse Events — 7.9 percentage of participants
N/A N=22 Evaluation of the Candela 1064nm:Nd:YAG Laser for Skin Tightening
Localized Lipodystrophy
Primary: Number of Participants With Mild to Moderate Reduction in Cellulite. — 3; 2 participants
N/A N=60 Non-Invasive Reduction of Abdominal Fat
Fat Reduction
Primary: Proportion of Pre-treatment Images Correctly Identified — 128 photos — p=<0.001
N/A N=11 Evaluation of Procedural Analgesia for Liposonix Treatment
Body Contouring
Primary: Pain Score for Overall Treatment — 6.3 units on a scale
N/A N=100 LSA Reconstruction With Laser Fenestration During the TEVAR
Type B Aortic Dissection
Primary: Freedom From All-cause Reintervention, All-cause Mortality and Major Adverse Events Within 30 Days After Procedure — 84 Participants
N/A N=15 Glaucoma Surgery Using the ViaLase Laser System
Glaucoma · Glaucoma, Open-Angle
Primary: Mean IOP — 12.7 mmHg